SCLC ClinicalImpact: New Tools and Expert Guidance for Integrating Immunotherapies

Get expert insights on the optimal integration of immunotherapies in the treatment of small-cell lung cancer with expert-authored commentaries a series of 10 brief interactive videos with downloadable slidesets and a new Interactive Decision Support Tool with expert recommendations individualized to your specific patient scenarios.

Share

Program Content

Activities

Frontline IO + CT in ES-SCLC
My Take on Frontline Chemoimmunotherapy for Extensive-Stage Small-Cell Lung Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 13, 2020

Expires: October 12, 2021

ES-SCLC Online Tool
An Interactive Treatment Decision Support Tool for Extensive-Stage SCLC
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 26, 2021

Expires: May 25, 2022

SCLC: WCLC 2020
Key Studies in Small-Cell Lung Cancer From the 2020 World Conference on Lung Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 01, 2021

Expires: February 28, 2022

Activities

LS-SCLC Management
Management of Limited-Stage SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2020

Expires: November 29, 2021

IO Rationale for ES-SCLC
Rationale for Using Immunotherapy in the Treatment of ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

First-line IO for ES-SCLC
Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Case: Frontline ES-SCLC
Case Discussion: Newly Diagnosed ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

Relapsed ES-SCLC
Overview of Therapeutic Options for Relapsed ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Case: Relapsed ES-SCLC
Case Discussion: Relapsed ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Case: Managing irAEs
Case Discussion: Management of Immune-Related AEs
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Radiation for ES-SCLC
Role of Radiation Therapy in the Management of ES-SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Biomarkers for IO in SCLC
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 01, 2021

Expires: January 31, 2022

IO Trials in SCLC
Key Clinical Trials of Immunotherapy in SCLC
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Activities

ES-SCLC Tool
Interactive Decision Support Tool: Expert Guidance on Treatment Selection for Patients With ES-SCLC
Tool
Congratulations: You achieved a completion on 04/09/2022

Released: May 24, 2021

Expires: May 23, 2022

Activities

IO Biomarkers
Biomarkers for Immunotherapy in SCLC: Where Are We and Where Are We Going?
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 01, 2021

Expires: January 31, 2022

LS-SCLC Management
Management of Limited-Stage SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Rationale for IO in ES-SCLC
Rationale for Using Immunotherapy in the Treatment of ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Firstline IO for ES-SCLC
Overview of Immunotherapy Options for Treatment-Naive ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Case: Frontline ES-SCLC
Case Discussion: Newly Diagnosed ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2020

Expires: December 08, 2021

Tx for Relapsed ES-SCLC
Overview of Therapeutic Options for Relapsed ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 01, 2020

Expires: November 30, 2021

Case: Relapsed ES-SCLC
Case Discussion: Relapsed ES-SCLC
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Case: irAE Management
Case Discussion: Management of Immune-Related AEs
Case Challenge
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 05, 2021

Expires: February 04, 2022

Radiation for ES-SCLC
Role of Radiation Therapy in the Management of ES-SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

SCLC IO Trials
Key Ongoing Clinical Trials of Immunotherapy in SCLC
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 02, 2021

Expires: February 01, 2022

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.